Advertisement

Advertisement

GB:OXB Stock Latest News

Oxford Biomedica Executives Exercise Deferred Bonus Options and Sell Shares

Company AnnouncementsOxford Biomedica Executives Exercise Deferred Bonus Options and Sell Shares

Oxford Biomedica reports PDMR share dealing by senior HR executive

PremiumCompany Announcements

Oxford Biomedica reports PDMR share dealing by senior HR executive

3d ago

Oxford Biomedica Executives Exercise Options and Sell Shares in Routine PDMR Dealings

PremiumCompany Announcements

Oxford Biomedica Executives Exercise Options and Sell Shares in Routine PDMR Dealings

9d ago

Oxford Biomedica shareholders back all AGM resolutions, reinforcing strategic flexibility

PremiumCompany Announcements

Oxford Biomedica shareholders back all AGM resolutions, reinforcing strategic flexibility

15d ago

Oxford Biomedica Confirms Total Voting Rights at 120.9 Million Shares

PremiumCompany Announcements

Oxford Biomedica Confirms Total Voting Rights at 120.9 Million Shares

22d ago

Oxford Biomedica Adds Employee Scheme Shares to London Listing

PremiumCompany AnnouncementsOxford Biomedica Adds Employee Scheme Shares to London Listing

23d ago

Oxford Biomedica Seeks Admission of New Shares Linked to Staff Incentive Plans

Company Announcements

Oxford Biomedica Seeks Admission of New Shares Linked to Staff Incentive Plans

25d ago

Oxford Biomedica unveils fast-track viral vector service to speed gene therapy development

Company Announcements

Oxford Biomedica unveils fast-track viral vector service to speed gene therapy development

1M ago

Oxford Biomedica Reinstates and Grants New Performance‑Linked Share Awards to Leadership

PremiumCompany Announcements

Oxford Biomedica Reinstates and Grants New Performance‑Linked Share Awards to Leadership

1M ago

Oxford Biomedica Confirms Updated Total Voting Rights

PremiumCompany Announcements

Oxford Biomedica Confirms Updated Total Voting Rights

2M ago

Oxford Biomedica sets date for 2026 AGM as it underscores cell and gene therapy CDMO role

PremiumCompany Announcements

Oxford Biomedica sets date for 2026 AGM as it underscores cell and gene therapy CDMO role

2M ago

Oxford BioMedica Returns to Profit as U.S. Expansion and Big Pharma Deals Lift Outlook

PremiumCompany Announcements

Oxford BioMedica Returns to Profit as U.S. Expansion and Big Pharma Deals Lift Outlook

2M ago

Oxford Biomedica resumed with a Buy at Jefferies

PremiumThe FlyOxford Biomedica resumed with a Buy at Jefferies

2M ago

OXB enters licensing agreement with Viral Vector Manufacturing Facility

The Fly

OXB enters licensing agreement with Viral Vector Manufacturing Facility

2M ago

Oxford Biomedica licenses viral vector platforms to Australian CDMO VVMF

Company Announcements

Oxford Biomedica licenses viral vector platforms to Australian CDMO VVMF

2M ago

Oxford Biomedica Adds Incentive Scheme Shares to London Listing

PremiumCompany Announcements

Oxford Biomedica Adds Incentive Scheme Shares to London Listing

2M ago

Oxford Biomedica Seeks LSE Admission for 92,381 New Incentive Shares

PremiumCompany Announcements

Oxford Biomedica Seeks LSE Admission for 92,381 New Incentive Shares

3M ago

Oxford Biomedica sets Capital Markets Day and tightens investor outreach calendar

PremiumCompany Announcements

Oxford Biomedica sets Capital Markets Day and tightens investor outreach calendar

3M ago

Oxford Biomedica Confirms Total Voting Rights at 120.9 Million Shares

PremiumCompany Announcements

Oxford Biomedica Confirms Total Voting Rights at 120.9 Million Shares

3M ago

Oxford Biomedica rejects EQT approaches as suitor walks away

PremiumCompany AnnouncementsOxford Biomedica rejects EQT approaches as suitor walks away

3M ago

Oxford Biomedica sees FY25 revenue GBP 166M -GBP 169M

The Fly

Oxford Biomedica sees FY25 revenue GBP 166M -GBP 169M

3M ago

Oxford Biomedica sees FY26 revenue GBP 220M -GBP 240M

The Fly

Oxford Biomedica sees FY26 revenue GBP 220M -GBP 240M

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >